Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)

A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies.

NCT00158860 ·Status: COMPLETED ·Phase: PHASE4

The Effect of Valacyclovir on the Detection of HIV From Genital Herpes Lesions in HIV-Infected Patients

NCT00002404 ·Status: COMPLETED ·Phase: NA

A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients

NCT00002000 ·Status: COMPLETED ·Phase: NA

A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients

NCT00002084 ·Status: COMPLETED ·Phase: NA

Randomized Trial to Evaluate Suppressive Effect of High-Dose Valacyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2

NCT01346475 ·Status: COMPLETED ·Phase: PHASE4

Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV

NCT00527618 ·Status: COMPLETED ·Phase: PHASE4

VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.

NCT00116844 ·Status: COMPLETED ·Phase: PHASE4

Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2

NCT00362297 ·Status: COMPLETED ·Phase: PHASE4

An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons

NCT01059084 ·Status: WITHDRAWN ·Phase: NA

Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes

NCT00306787 ·Status: COMPLETED ·Phase: PHASE3

Effect of Valacyclovir in the Reduction of HSV-2 Recurrence and Shedding

NCT00803543 ·Status: COMPLETED ·Phase: NA

Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir

NCT01689285 ·Status: COMPLETED ·Phase: PHASE1

The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Children

NCT00001054 ·Status: WITHDRAWN ·Phase: PHASE1

Pharmacokinetic Interaction Study of Steady-state Tipranavir/Ritonavir (TPV/r) With Single-dose Valaciclovir (VAL) in Healthy Volunteers

NCT02226978 ·Status: COMPLETED ·Phase: PHASE1

A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes

NCT00486200 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes

NCT01658826 ·Status: TERMINATED ·Phase: PHASE2

Fed Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mg

NCT00650494 ·Status: COMPLETED ·Phase: PHASE1

Valaciclovir to Prevent Transmission of Herpes Simplex Virus

NCT00001649 ·Status: COMPLETED ·Phase: PHASE3

Long Term Treatment of Herpes Simplex Encephalitis (HSE) With Valacyclovir

NCT00031486 ·Status: COMPLETED ·Phase: PHASE3

Evaluation Of Valaciclovir In Patients With Chickenpox

NCT00169416 ·Status: COMPLETED ·Phase: PHASE3

Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fasting Conditions

NCT01132729 ·Status: COMPLETED ·Phase: NA

Palatability Testing of a New Paediatric Formulation of Valacyclovir

NCT01682109 ·Status: COMPLETED ·Phase: PHASE4

A Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia

NCT02412917 ·Status: TERMINATED ·Phase: PHASE3

Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I)

NCT01453075 ·Status: COMPLETED ·Phase: PHASE1

A Study of Valacyclovir Hydrochloride in the Prevention of Life-Threatening Cytomegalovirus Disease in HIV-Infected Patients

NCT00001038 ·Status: COMPLETED ·Phase: PHASE3